NEUP Neuphoria Therapeutics Inc. - Common Stock
$3.95
Price · Aug 19, 2026
Fundamentals as of May 15, 2026
52W Range
$3–$21
4% of range
Analyst Rating
HOLD
6 analysts
Price Target
$7
+77% upside
P/E (TTM)
-17.2
ROE
-2.3%
Net Profit Margin
-2.4%
NEUP Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$3.95
Market Cap
$8M
P/E (TTM)
-17.2
EPS (TTM)
$-0.23
Revenue (TTM)
$16M
Div Yield
—
ROE
-2.3%
Debt/Equity
—
52W Range
$3 – $21
NEUP Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
$16M
2025-06-30
→
2025-06-30
EPS
$-0.23
2023-06-30
→
2025-06-30
Free Cash Flow
—
Margins
-2.4%
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
NEUP
Peer Median
P/E (TTM)
-17.2
—
P/S (TTM)
0.5
1.3
P/B
0.4
0.7
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
NEUP
Peer Median
Operating Margin
-7.2%
—
Net Profit Margin
-2.4%
59.5%
ROA
-1.3%
-1353.2%
ROE
-2.3%
-910.3%
ROIC
-2.6%
—
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
NEUP
Peer Median
Current Ratio
3.6
7.2
Quick Ratio
3.4
—
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
NEUP
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
NEUP
Peer Median
NEUP Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
SELL
6 analysts
- Strong Buy 0 0.0%
- Buy 0 0.0%
- Hold 3 50.0%
- Sell 1 16.7%
- Strong Sell 2 33.3%
12-Month Price Target
1 analysts · 2026-05-17
Low
$7.00
High
$7.00
Median target
$7.00
+77.2%
Mean target
$7.00
+77.2%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-1.3%
Next Report
Sep 28, 2026
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| Sept. 30, 2026 | $-0.09 | $-0.57 | — |
| March 31, 2026 | $-0.09 | $-0.99 | 0.90% |
| Dec. 31, 2025 | $-0.77 | $-1.49 | 0.72% |
| Sept. 30, 2025 | $-4.41 | $-1.35 | -3.1% |
| June 30, 2025 | $-5.79 | $-2.12 | -3.7% |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| NEUP | $14M | -30.9 | — | -2.4% | -2.3% | — |
| PPCB | $48M | -0.3 | — | — | -1209.0% | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 15
| Metric | Trend | 2025 |
|---|---|---|
| Revenue | $16M | |
| R&D Expense | $9M | |
| SG&A Expense | $8M | |
| Operating Expenses | $17M | |
| Operating Income | $-1M | |
| Interest Income | $166.5K | |
| Other Non-op | $291.1K | |
| Pretax Income | $-838.0K | |
| Income Tax | $-468.4K | |
| Net Income | $-400.0K | |
| EPS (Basic) | $-0.23 | |
| EPS (Diluted) | $-0.23 | |
| Shares (Basic) | 1,622,924 | |
| Shares (Diluted) | 1,622,924 | |
| EBITDA | $-1M |
Balance Sheet 19
| Metric | Trend | 2025 |
|---|---|---|
| Cash & Equivalents | $14M | |
| Receivables | $11.9K | |
| Prepaid Expense | $740.2K | |
| Current Assets | $15M | |
| PP&E (Net) | $2.8K | |
| Goodwill | $9M | |
| Intangibles | $5M | |
| Total Assets | $29M | |
| Accounts Payable | $1M | |
| Current Liabilities | $4M | |
| Deferred Tax | $495.1K | |
| Total Liabilities | $10M | |
| Common Stock | $19 | |
| Paid-in Capital | $200M | |
| Retained Earnings | $-178M | |
| AOCI | $-3M | |
| Stockholders' Equity | $19M | |
| Liabilities + Equity | $29M | |
| Shares Outstanding | 1,978,460 |
Cash Flow 8
| Metric | Trend | 2025 |
|---|---|---|
| D&A | $662.9K | |
| Stock-based Comp | $163.8K | |
| Deferred Tax | $-468.4K | |
| Operating Cash Flow | $77.2K | |
| Stock Issued | $2M | |
| Net Stock Activity | $2M | |
| Financing Cash Flow | $2M | |
| Net Change in Cash | $2M |
Profitability 7
| Metric | Trend | 2025 |
|---|---|---|
| Operating Margin | -7.2% | |
| Net Margin | -2.4% | |
| Pretax Margin | -5.3% | |
| EBITDA Margin | -7.2% | |
| ROA | -1.3% | |
| ROE | -2.3% | |
| ROIC | -2.6% |
Liquidity & Solvency 2
| Metric | Trend | 2025 |
|---|---|---|
| Current Ratio | 3.6 | |
| Quick Ratio | 3.4 |
Efficiency 2
| Metric | Trend | 2025 |
|---|---|---|
| Asset Turnover | 0.6 | |
| Receivables Turnover | 225.4 |
Valuation (TTM) 9
| Metric | Trend | 2025 |
|---|---|---|
| Revenue TTM | $16M | |
| Net Income TTM | $-400.0K | |
| Market Cap | $14M | |
| P/E | -30.9 | |
| P/S | 0.9 | |
| P/B | 0.7 | |
| P / Tangible Book | 2.5 | |
| P / Cash Flow | 181.9 | |
| Earnings Yield | -3.2% |
Income Statement 15
| Metric | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | $-13.3K | $15M | $662.7K | |
| R&D Expense | · | $697.7K | $4M | $4M | $2M | $2M | |
| SG&A Expense | $2M | $2M | $2M | $2M | $1M | $3M | |
| Operating Expenses | $1M | $4M | $6M | $6M | $3M | $4M | |
| Operating Income | $-1M | $-4M | $-6M | $-6M | $12M | $-4M | |
| Interest Income | $186.2K | $167.3K | $142.0K | $87.0K | $12.7K | $30.6K | |
| Other Non-op | $671.8K | $6M | $-4M | $-3M | $-796.2K | $2M | |
| Pretax Income | $-539.9K | $2M | $-10M | $-9M | $11M | $-2M | |
| Income Tax | $-34.8K | $-34.8K | $-34.8K | $-266.6K | $-81.2K | $11.6K | |
| Net Income | $-505.1K | $2M | $-10M | $-9M | $11M | $-2M | |
| EPS (Basic) | $-0.09 | $0.41 | $-4.41 | $-4.93 | $6.55 | $-1.23 | |
| EPS (Diluted) | $-0.09 | $-0.77 | $-4.41 | $-4.37 | $6.55 | $-1.79 | |
| Shares (Basic) | 5,411,244 | 4,536,235 | 2,246,066 | -2,971,458 | 1,719,073 | 1,575,244 | |
| Shares (Diluted) | 5,411,244 | 4,536,235 | 2,246,066 | -2,971,458 | 1,719,073 | 1,575,244 | |
| EBITDA | $-1M | $-4M | $-6M | · | $12M | $-4M |
Balance Sheet 21
| Metric | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $19M | $22M | $14M | $14M | $17M | $4M | |
| Receivables | $2M | $1M | $1.8K | $11.9K | $24.6K | $35.6K | |
| Prepaid Expense | $611.9K | $27.0K | $222.3K | $740.2K | $20.9K | $18.5K | |
| Current Assets | $22M | $23M | $14M | $15M | $17M | $4M | |
| PP&E (Net) | · | · | $2.6K | $2.8K | $1.6K | $1.7K | |
| Goodwill | $9M | $9M | $9M | $9M | $8M | $8M | |
| Intangibles | $4M | $4M | $5M | $5M | $5M | $5M | |
| Total Assets | $35M | $37M | $27M | $29M | $31M | $18M | |
| Accounts Payable | $627.2K | $520.7K | $1M | $1M | $745.3K | $2M | |
| Current Liabilities | $2M | $3M | $5M | $4M | $2M | $2M | |
| Capital Leases | · | · | · | · | $19.3K | $49.8K | |
| Deferred Tax | $390.7K | $425.5K | $460.3K | $495.1K | $761.7K | $842.9K | |
| Other Non-current Liabilities | · | · | · | · | $3.6K | $3.4K | |
| Total Liabilities | $5M | $7M | $15M | $10M | $5M | $4M | |
| Common Stock | $54 | $54 | $23 | $19 | $19 | $16 | |
| Paid-in Capital | $218M | $218M | $204M | $200M | $199M | $198M | |
| Retained Earnings | $-187M | $-186M | $-188M | $-178M | $-169M | $-181M | |
| AOCI | $-2M | $-2M | $-3M | $-3M | $-4M | $-4M | |
| Stockholders' Equity | $29M | $30M | $13M | $19M | $26M | $14M | |
| Liabilities + Equity | $35M | $37M | $27M | $29M | $31M | $18M | |
| Shares Outstanding | 5,377,329 | 5,377,329 | 2,357,613 | 1,978,460 | 1,853,966 | 1,628,659 |
Cash Flow 8
| Metric | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|---|
| D&A | $165.7K | $165.8K | $165.8K | $165.6K | $165.4K | $166.1K | |
| Stock-based Comp | $70.3K | $93.7K | $111.3K | $98.3K | $19.7K | $19.1K | |
| Restructuring | $42.4K | $1M | · | · | · | · | |
| Operating Cash Flow | $-3M | $-6M | $-4M | $-4M | $11M | $-3M | |
| Stock Issued | $0 | $15M | $3M | $704.7K | $823.6K | $0 | |
| Net Stock Activity | · | · | $3M | · | · | · | |
| Financing Cash Flow | $0 | $15M | $3M | $704.7K | $1M | $-111.6K | |
| Net Change in Cash | $-3M | $9M | $-560.5K | $-3M | $13M | $-4M |
Profitability 7
| Metric | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | 79.8% | -558.8% | |
| Net Margin | · | · | · | · | 75.1% | -293.2% | |
| Pretax Margin | · | · | · | · | 74.5% | -291.5% | |
| EBITDA Margin | · | · | · | · | 79.8% | -558.8% | |
| ROA | -1.5% | 6.8% | -39.4% | · | 73.3% | -21.4% | |
| ROE | -1.8% | 8.6% | -67.0% | · | 86.6% | -28.3% | |
| ROIC | -3.9% | -13.9% | -45.0% | · | 46.4% | -27.1% |
Liquidity & Solvency 2
| Metric | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 14.3 | 9.0 | 2.7 | · | 11.0 | 2.1 | |
| Quick Ratio | 13.9 | 9.0 | 2.7 | · | 11.0 | 2.1 |
Efficiency 2
| Metric | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | 1.0 | 0.1 | |
| Receivables Turnover | · | · | · | · | 1219.9 | 37.3 |
Valuation (TTM) 7
| Metric | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $3M | $1M | $-1M | · | $6M | $-10M | |
| Market Cap | $22M | $21M | $28M | · | $11M | $6M | |
| P/E | 3.2 | -9.2 | -43.7 | · | 4.4 | -0.3 | |
| P/B | 0.7 | 0.7 | 2.2 | · | 0.4 | 0.4 | |
| P / Tangible Book | 1.3 | 1.3 | · | · | 0.8 | 27.3 | |
| P / Cash Flow | · | · | -7.3 | · | · | · | |
| Earnings Yield | 31.4% | -10.8% | -2.3% | · | 22.7% | -307.6% |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-06-30 | 2024-06-30 | 2023-06-30 | |
|---|---|---|---|
| Revenue | $16M | — | — |
| Operating Margin % | -7.2% | — | — |
| Net Income | $-400.0K | $-15M | $-21M |
| Diluted EPS | $-0.23 | $-18.62 | $-0.02 |
Balance Sheet
| 2025-06-30 | 2024-06-30 | 2023-06-30 | |
|---|---|---|---|
| Current Ratio | 3.6 | 3.4 | — |
| Quick Ratio | 3.4 | 3.3 | — |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 23 filers · $8.5M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 6 (0 vs prior Q) | 3 (-4 vs prior Q) | 7 (+3 vs prior Q) | 1 (-1 vs prior Q) | +231K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Lynx1 Capital Management LP | $3,825,183 | 875,328 | 45.15% | Shares |
| AdvisorShares Investments LLC | $1,105,212 | 252,909 | 13.04% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $758,143 | 173,488 | 8.95% | Shares |
| Shay Capital LLC | $680,942 | 155,822 | 8.04% | Shares |
| Balyasny Asset Management L.P. | $621,536 | 142,228 | 7.34% | Shares |
| CITADEL ADVISORS LLC | $317,083 | 72,559 | 3.74% | Shares |
| Ikarian Capital, LLC | $207,326 | 47,443 | 2.45% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $177,269 | 40,565 | 2.09% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $147,732 | 33,806 | 1.74% | Shares |
| ADAR1 Capital Management, LLC | $131,100 | 30,000 | 1.55% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $111,435 | 25,500 | 1.32% | Shares |
| XTX Topco Ltd | $100,899 | 23,089 | 1.19% | Shares |
| BOOTHBAY FUND MANAGEMENT, LLC | $61,180 | 14,000 | 0.72% | Shares |
| COMMONWEALTH EQUITY SERVICES, LLC | $49,040 | 11,222 | 0.58% | Shares |
| NORTHERN TRUST CORP | $46,366 | 10,610 | 0.55% | Shares |
| Merck & Co., Inc. | $43,818 | 10,027 | 0.52% | Shares |
| VANGUARD GROUP INC | $42,959 | 11,072 | 0.51% | Shares |
| JANE STREET GROUP, LLC | $35,729 | 8,176 | 0.42% | Shares |
| UBS Group AG | $9,251 | 2,117 | 0.11% | Shares |
| FNY Investment Advisers, LLC | $115 | 26,500 | 0.00% | Shares |
| HRT FINANCIAL LP | $99 | 22,865 | 0.00% | Shares |
| MORGAN STANLEY | $31 | 7 | 0.00% | Shares |
| Caitong International Asset Management Co., Ltd | $13 | 3 | 0.00% | Shares |
Company insiders 5 insiders · 1 officers · 5 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Spyros Papapetropoulos | President and CEO | Aug. 27, 2025 A | — | 0 | 0 | $0 |
| Peter Miles Winston Davies | Director | Jan. 20, 2026 A | — | 0 | 0 | $0 |
| David Ian Wilson | Director | Jan. 20, 2026 A | — | 0 | 0 | $0 |
| Jane Ryan | Director | Jan. 20, 2026 A | — | 0 | 0 | $0 |
| Alan Fisher | Director | Jan. 20, 2026 A | — | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Activists & 5%+ owners 2 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Lynx1 Capital Management LP, Weston Nichols ×6 filings | Dec. 29, 2025 | 16.30% | Amendment | — | SEC |
| Apeiron Investment Group Ltd., Apeiron Presight Capital Fund II, L.P., Presight Capital Management I, L.L.C., Fabian Hansen, Christian Angermayer ×3 filings | Jan. 28, 2025 | 4.50% | Amendment | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF ownership Held by 2 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.